The trials and tribulations in pharma sector may continue in the new year

 

The trials and tribulations in pharma sector may continue in the new year

Ltd. In fact, most pharma stocks that got observation letters, OAI letters, or warning letters went into a tailspin. As the US FDA inspects about 400 manufacturing plants in India every two years, …

More The trials and tribulations in pharma sector may continue in the new year Videos

Leave a Reply